Genialis, Inventia to enhance pancreatic cancer treatments testing

Genialis and Inventia Life Science have partnered to enhance pancreatic cancer treatment testing and match them to the patients who are likely to benefit. The companies will combine Genialis Supermodel with Inventia’s RASTRUM 3D model platform to study PDAC. RASTRUM creates 3D pancreatic cancer models in which tumour and stromal components can be controlled and altered independently. Credit: sasirin pamai / Shutterstock.com. Genialis has teamed up with Inventia Life Science to enhance the testing of pancreatic cancer treatments and match them to the patients who are likely to benefit. The companies will integrate the Genialis Supermodel with Inventia’s RASTRUM 3D…

Source: Pharmaceutical Technology